Genetron Health Announces Receipt Of Notification From Nasdaq
Portfolio Pulse from Benzinga Newsdesk
Genetron Health (NASDAQ:GTH) has received a notification from Nasdaq stating that its closing bid price has been below the minimum $1.00 per share requirement for the last 30 consecutive business days. The company has until November 13, 2023, to regain compliance.
May 23, 2023 | 8:32 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Genetron Health's stock price is at risk due to non-compliance with Nasdaq's minimum bid price requirement, potentially affecting its listing status.
Genetron Health has been notified by Nasdaq for not meeting the minimum bid price requirement for the last 30 consecutive business days. This puts the company's stock price at risk and may affect its listing status if it fails to regain compliance by November 13, 2023. Investors may be concerned about the company's ability to meet the requirement, which could negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100